These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 12842123

  • 1. The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade.
    Leriche L, Schwartz JC, Sokoloff P.
    Neuropharmacology; 2003 Aug; 45(2):174-81. PubMed ID: 12842123
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice.
    Cook CD, Newman JL, Winfree JC, Beardsley PM.
    Pharmacol Biochem Behav; 2004 Feb; 77(2):309-18. PubMed ID: 14751459
    [Abstract] [Full Text] [Related]

  • 4. Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism.
    Ouagazzal A, Amalric M.
    Eur J Pharmacol; 1995 Dec 27; 294(1):137-46. PubMed ID: 8788425
    [Abstract] [Full Text] [Related]

  • 5. Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics.
    Bradford AM, Savage KM, Jones DN, Kalinichev M.
    Psychopharmacology (Berl); 2010 Oct 27; 212(2):155-70. PubMed ID: 20676613
    [Abstract] [Full Text] [Related]

  • 6. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
    Mele A, Castellano C, Felici A, Cabib S, Caccia S, Oliverio A.
    Eur J Pharmacol; 1996 Jul 11; 308(1):1-12. PubMed ID: 8836626
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice.
    Boulay D, Bergis O, Avenet P, Griebel G.
    Neuropsychopharmacology; 2010 Jan 11; 35(2):416-27. PubMed ID: 19759529
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.
    Leite JV, Guimarães FS, Moreira FA.
    Eur J Pharmacol; 2008 Jan 14; 578(2-3):222-7. PubMed ID: 18021764
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Locomotor activity induced by the non-competitive N-methyl-D-aspartate antagonist, MK-801: role of nucleus accumbens efferent pathways.
    De Leonibus E, Mele A, Oliverio A, Pert A.
    Neuroscience; 2001 Jan 14; 104(1):105-16. PubMed ID: 11311535
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice.
    Okuyama S, Imagawa Y, Tomisawa K.
    Neuropharmacology; 1996 Apr 14; 35(4):467-74. PubMed ID: 8793909
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of the locomotor responses induced by D1-like and D2-like dopamine receptor agonists and D-amphetamine by NMDA and non-NMDA glutamate receptor agonists and antagonists in the core of the rat nucleus accumbens.
    David HN, Sissaoui K, Abraini JH.
    Neuropharmacology; 2004 Feb 14; 46(2):179-91. PubMed ID: 14680757
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.